The intersection of sports marketing and the pharmaceutical industry offers a dynamic space where brands can leverage ...

Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time Consolidated revenue up 2.7% to EUR 890.1 million. Growth in high-margin ...

Out-of-home posters using the term “HER2.0” showed that the drug could also be used to fight gastrointestinal cancers.

Shares of Hikma Pharmaceuticals PLC HIK inched up 0.33% to £18.37 Monday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.65% to ...